General Announcement::Notification to stock exchange

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Dec-2024 11:42:21
Status
New
Announcement Sub Title
Notification to stock exchange
Announcement Reference
SG241230OTHR69AA
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Biocon Biologics has fulfilled its obligations towards all deferred milestones under the acquisition agreement with Viatris. This also marks, as full and final remittance of considerations from Biocon Biologics toward Viatris for the acquisition.

Attachments

BBL_Notification_SGX_30122024.pdf
Total size =254K